Pricing Log in Create free account

Gossamer Bio, Inc. (GOSS) vs Rein Therapeutics Inc. (RNTX)

Gossamer Bio, Inc. and Rein Therapeutics Inc. are both Biotechnology companies. Gossamer Bio, Inc. and Rein Therapeutics Inc. are of similar size ($54.3M and $54.2M). Rein Therapeutics Inc. has the higher net margin (0.00% vs −235.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Rein Therapeutics Inc. leads on 7 and Gossamer Bio, Inc. on 5.

Valuation

Metric GOSS RNTX Biotechnology median
P/E n/m n/m 8.50
P/S 0.65 n/m 9.71
P/B n/m 3.88 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.03 0.64
EV/Sales 3.99 n/m 9.21
Earnings yield (526.56%) (291.53%) (33.15%)
Free cash flow yield (469.68%) (47.32%) (25.50%)

Profitability

Metric GOSS RNTX Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (311.70%) 0.00% 0.00%
Net margin (235.00%) 0.00% 0.00%
Free cash flow margin (305.19%) 0.00% 0.00%
Return on equity 178.72% (753.55%) (56.36%)
Return on assets (78.81%) (80.62%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GOSS RNTX Biotechnology median
Revenue growth (TTM) 32.43% — 6.02%
EPS growth (last fiscal year) (200.00%) 44.16% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GOSS RNTX Biotechnology median
Debt to equity (0.38) 0.00 0.00
Current ratio 0.53 4.27 4.72
Net debt to EBITDA (0.35) 0.15 0.96

Dividend

Metric GOSS RNTX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GOSS RNTX Biotechnology median
Market cap 54.32m 54.17m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack